다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

EVOK

Evoke Pharma (EVOK)

Evoke Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EVOK

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	05:02	GlobeNewswire Inc.	Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05:58	Edgar (US Regulatory)	Form ARS/A - Annual Report to Security Holders: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05:15	GlobeNewswire Inc.	Evoke Pharma Reports First Quarter 2024 Financial Results	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05:05	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/04/17	21:30	GlobeNewswire Inc.	Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications	NASDAQ:EVOK	Evoke Pharma Inc
2024/03/22	05:15	GlobeNewswire Inc.	Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer	NASDAQ:EVOK	Evoke Pharma Inc
2024/03/15	05:05	GlobeNewswire Inc.	Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:EVOK	Evoke Pharma Inc
2024/03/08	06:10	GlobeNewswire Inc.	Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/24	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/21	06:38	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/14	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/14	21:30	GlobeNewswire Inc.	Evoke Pharma Announces Closing of $7.5 Million Public Offering	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/10	07:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/10	07:14	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/09	21:30	GlobeNewswire Inc.	Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/09	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/08	20:50	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2024/01/11	11:38	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2024/01/05	06:30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2023/12/19	22:30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2023/12/16	06:30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2023/11/29	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2023/11/28	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2023/11/27	22:30	GlobeNewswire Inc.	Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent	NASDAQ:EVOK	Evoke Pharma Inc
2023/11/23	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2023/11/14	22:30	GlobeNewswire Inc.	United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI	NASDAQ:EVOK	Evoke Pharma Inc
2023/11/10	06:30	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:EVOK	Evoke Pharma Inc

검색 관련기사 보기:NASDAQ:EVOK

1 2 3 4 5 6 7 8 9 10 다음 >>

SUNBLOCKTERMINAL

Canada Tf 2,75% Dc48 Cad

Brookfield Select Opport...

Greenfield Online

StockChain Coin

Bnp Paribas null

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관